Application of mdl-800 in the preparation of drugs for inhibiting susceptibility to sars-cov-2 virus
A technology of MDL-800, 1. MDL-800 is applied in the application field of preparing medicines for inhibiting SARS-CoV-2 virus susceptibility, and can solve the problems such as no reports on MDL-800 anti-coronavirus medicines.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0045] Example 1, MDL-800 inhibits the susceptibility of SARS-CoV-2 to cells
[0046] (1) Construction of Caco-2 and Calu-3 cell lines stably expressing luciferase Rluc
[0047] In order to construct Caco-2 and Calu-3 cell lines stably expressing Renilla-luciferase (RLuc), we first packaged Rluc lentiviral particles (RLuc lentiviral expression vector pHHLVX-EF1α-Rluc-puro was purchased from HedgehogBio Science and Technology Ltd ).
[0048] First, HEK293T cells were cultured in T-75 cell culture flasks with 15ml DMEM medium containing 10% fetal bovine serum until the density reached 70%; 2.8μg), VSV-G (3.92μg) and pHHLVX-EF1α-Rluc-puro (7μg), and 58.8μl PEI (1mg / ml) were mixed in 1.5ml serum-free DMEM, reacted at room temperature for 15 minutes and added to HEK293T cells . Change the medium 6 hours after transfection; 48 hours after transfection, centrifuge at 1000g for 10 minutes to remove cell debris, collect the supernatant, then filter with a 0.45μm filter, place the fi...
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 


